+ Filter
Loading...
Cixutumumab
Anti-Cixutumumab Recombinant Antibody Products
- DrugMonitor™ Anti-Cixutumumab Antibody (VS-1224-YC284) (VS-1224-YC284)
-
- Specificity: Cixutumumab
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, PK/PD, ADA control
Compare
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Cixutumumab has been evaluated in clinical trials for treating lung cancer, malignant neoplasms, leukemia, mast-cell neoplasms, non-small-cell lung carcinoma, and adenocarcinoma of the prostate, known for its high affinity for the insulin-like growth factor-I receptor (IGF-IR) overexpressed in various tumors.